Heptares Therapeutics' Corporate Minority Round

Heptares Therapeutics raised a round of funding on May 18, 2017. Investors include Teva Pharmaceuticals.

Heptares Therapeutics focuses on the discovery and development of novel drugs acting at G-protein coupled receptors (GPCRs). Heptares StaR (Stabilized Receptor) technology enables thermo-stabilization…

Articles about Heptares Therapeutics' Corporate Minority Round: